LATEST
Intelligent Protection Management agreed to acquire AdTech ITnewJanel agreed to acquire EnCor BiotechnologyNightfood Holdings acquired Jun Long Machine IndustrialClimb Global Solutions acquired NeoVADValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range Intermediate
Open App
ClosedPublished 6 Jan 2022

Cumberland Pharmaceuticals Inc. /
Kyowa Kirin

Cumberland Pharmaceuticals acquires U.S. SANCUSO rights

Price
$13.5m
Stage
Closed
Source · 6 Jan 2022
See the source
01 / BuyerCumberland Pharmaceuticals Inc.
02 / TargetKyowa Kirin
01

What happened

Cumberland Pharmaceuticals Inc. completed its purchase of the U.S. rights to SANCUSO from Kyowa Kirin, Inc. on Jan. 3, 2022.

Cumberland paid $13.5 million at closing. Additional payments include milestones of up to $3.5 million and tiered royalties on future U.S. net sales.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Cumberland Pharmaceuticals acquires U.S. SANCUSO rights

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.